EDI-OCT was used in another study to detect choroidal thickness changes in AMD patients after anti-VEGF therapy.33 These studies may be valuable for guiding anti-VEGF treatment protocols, especially when discussing a side effect like the development of geographic atrophy. This evidence concerns the gene VEGFA and age-related macular degeneration.